Medical therapy for chronic gastrointestinal bleeding of obscure origin

American Journal of Gastroenterology

Volumn 93, Issue 8, 1998, Pages 1250-1254

  Barkin, Jamie S ^a,b   Ross, Barry S ^a  

^a UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

^b MOUNT SINAI MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CONJUGATED ESTROGEN; ESTRADIOL; MESTRANOL PLUS NORETHISTERONE; MESTRANOL PLUS NORETYNODREL; ORGEN; UNCLASSIFIED DRUG;

ADULT; AGED; ARTERIOVENOUS MALFORMATION; ARTICLE; CLINICAL ARTICLE; DIAGNOSTIC APPROACH ROUTE; DRUG EFFICACY; DRUG SAFETY; FEMALE; GASTROINTESTINAL HEMORRHAGE; GENITAL SYSTEM DISEASE; GYNECOMASTIA; HEMATOCRIT; HORMONAL THERAPY; HUMAN; MALE; MASTALGIA; OCCULT BLOOD; PRIORITY JOURNAL; RECURRENT DISEASE;

AGED; AGED, 80 AND OVER; CHRONIC DISEASE; COMBINED MODALITY THERAPY; CONTRACEPTIVES, ORAL, COMBINED; DRUG COMBINATIONS; DRUG EVALUATION; ELECTROCOAGULATION; ENDOSCOPY, GASTROINTESTINAL; ESTRADIOL CONGENERS; FEMALE; GASTROINTESTINAL AGENTS; GASTROINTESTINAL HEMORRHAGE; HUMANS; MALE; MESTRANOL; MIDDLE AGED; NORETHINDRONE; NORETHYNODREL; OCCULT BLOOD; PROSPECTIVE STUDIES; RECURRENCE;

EID: 0032148064     PISSN: 00029270     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1572-0241.1998.404_i.x     Document Type: Article

References (32)

1. 1. Barkin JS, Reiner DK, Lewis BS, et al. Diagnostic and therapeutic jejunoscopy with the SIF-10L enteroscope: Longer is really better. Gastrointest Endosc 1991;36:214.
2. 2. Barkin JS, Lewis BS, Reiner DK, et al. Diagnostic and therapeutic jejunoscopy with a new, longer enteroscope. Gastrointest Endosc 1992;38:55-8.
3. 3. Barkin JS, Reiner DK. Diagnostic and therapeutic jejunoscopy with the SIF-10.5L new enteroscope. Am J Gastroenter 1992;87:1311.
4. 4. Barkin JS, Reiner DK. Third generation push-type enteroscopy using an overtube. Gastrointest Endos 1993;39:248.
5. 5. Lewis BS, Wenter JS, Waye JD. Small bowel enteroscope and intraoperative enteroscopy for obscure gastrointestinal bleeding. Am J Gastroenterol 1991;86:171-4.
6. 6. Clouse R, Costigan D, Mills B, et al. Angiodysplasia as a cause of upper gastrointestinal bleeding. Arch Intern Med 1985;145:458-61.
7. 7. Richter JM, Hedberg S, Athanasoulos C, et al. Angiodysplasia: Clinical presentation and colonoscopic diagnosis. Dig Dis Sci 1984;29: 481-5.
8. 8. Van Cutsem E, Rutgeerts P, Vantrappen G. Treatment of bleeding gastrointestinal vascular malformations with oestrogen-progesterone. Lancet 1990;335:953-5.
9. 9. Richter JM, Christensen MR, Colditz JA, et al. Angiodysplasia: Natural history and efficacy of therapeutic interventions. Dig Dis Sci 1989;34:1542-6.
10. 10. Lanthier PH, D'Harvey B, Vanheuverzwyn R, et al. Colonic angiodysplasia: Follow-up of patients after endoscopic treatment for bleeding lesions. Dis Colon Rectum 1989;32:296-8.
11. 11. Barkin JS, Rosen S. Enteroscopy. In: Barkin JS, O'Phelan CA, eds. Advanced therapeutic endoscopy. New York: Raven Press, 1990: 163-8.
12. 12. Bernstein DA, Barkin JS. Enteroscopy. Pract Gastroenterol 1993;17: 12B-12J.
13. 13. Howard OM, Buchanan JD, Hunt RTL. Angiodysplasia of the colon: Experience of 26 cases. Lancet 1982;2:16-9.
14. 14. Granieri R, Wazzulla JP, Yarborough GW. Estrogen-progesterone therapy of recurrent gastrointestinal bleeding secondary to gastrointestinal angiodysplasia. Am J Gastroenterol 1988;83:556-8.
15. 15. Van Cutsem E, Rutgeerts P, Geboes K, et al. Estrogen-progesterone treatment of Olser-Weber-Rendu disease. J Clin Gastroenterol 1988; 10:676-9.
16. 16. McGee R. Estrogen-progesterone therapy for gastrointestinal bleeding in hereditary hemorrhagic telangiectasia. South Med J 1979;10:676-9.
17. 17. Bronner MG, Pate MB, Cunningham JT, et al. Estrogen-progesterone therapy for bleeding telangiectasias in chronic renal failure: An uncontrolled trial. Ann Intern Med 1986; 105:352-4.
18. 18. Lewis BS, Salomon P, Rivera-MacMurray S, et al. Does hormonal therapy have any benefit for bleeding angiodysplasia. J Clin Gastroenterol 1992;15:99-103.
19. 19. Koch H, Escher G, Lewis J. Hormonal management of hereditary hemorrhagic telangiectasis. JAMA 1952;149:1376-80.
20. 20. Reilly PJ, Nostrant TT. Clinical manifestations of hereditary hemorrhagic telangiectasia. Am J Gastroenterol 1984;79:363-7.
21. 21. Menefee MG, Plessa HC, Glueck HI, et al. Hereditary hemorrhagic telangiectasia (Osler-Weber-Rendu disease): An electron microscopic study of the vascular lesions before and after therapy with hormones. Arch Otolaryngol 1975;101:246-51.
22. 22. Richtsmeier W, Weave RG, Streck W, et al. Estrogen and progesterone receptors in hereditary hemorrhagic telangiectasia. Otolaryngol Head Neck Surg 1984;92:564-70.
23. 23. Lavabre-Bertrand T, Navarro M, Blanc P, et al. Von Willebrand's disease, digestive angiodysplasia and estrogen-progesterone treatment (letter). Am J Hematol 1994;45:254-5.
24. 24. Roberts HJ. The control of nonvariceal gastrointestinal hemorrhage. Medical Times 1961;89:603-9.
25. 25. Lewis BS, Kornbluth AA. Hormonal therapy for bleeding from angiodysplasia: Chronic renal failure. Am J Gastroenterol 1990;85:1649-50.
26. 26. Foutch RG. Angiodysplasia of the gastrointestinal tract. Am J Gastroenterol 1993;88:807-18.
27. 27. Liu Y, Kosfeld R, Marcum S. Treatment of uremia bleeding with conjugated estrogens. Lancet 1984;184:887-90.
28. 28. Livio M, Mannucci P, Vigano G. Conjugated estrogens for the management of bleeding associated with renal failure. N Engl J Med 1986;315:731-5.
29. 29. Nagamine Y, Komatsu S, Suzki J. New embolization method using estrogen: effect of estrogen on microcirculation. Surg Neurol 1983; 20:269-75.
30. 30. Moshkowitz M, Asher N, Amir N, et al. Success of estrogen-progesterone therapy in long standing bleeding gastrointestinal angiodysplasia: Report of a case. Dis Colon Rectum 1993;36:194-6.
31. 31. Soupison A, Pariot G, Bernard P. Angiodysplasia et pilule. Gastroenterologic Clinique et Biologique 1993;17:152-3.
32. 32. Harrison D. Use of estrogen in treatment of familial hemorrhagic telangiectasia. Laryngoscope 1982;92:314-9.